Auteurs
Analysis
Canada
Racine
Analysis
Canada
Exploration
Accueil
Racine
Racine

Serveur d'exploration sur les relations entre la France et l'Australie - Analysis (Canada)

Index « Auteurs » - entrée « Mansoor Raza Mirza »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Mansoor R. Mirza < Mansoor Raza Mirza < Mansoor Saleh  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 2.
Ident.Authors (with country if any)Title
000C87 (2014) Martin R. Stockler [Australie] ; Felix Hilpert [Allemagne] ; Michael Friedlander [Australie] ; Madeleine T. King [Australie] ; Lari Wenzel [Canada] ; CHEE KHOON LEE [Australie] ; Florence Joly [France] ; Nikolaus De Gregorio [Allemagne] ; José Angel Arranz [Espagne] ; Mansoor Raza Mirza [Danemark] ; Roberto Sorio [Italie] ; Ulrich Freudensprung [Suisse] ; Vesna Sneller [Australie] ; Gill Hales [Australie] ; Eric Pujade-Lauraine [France]Patient-Reported Outcome Results From the Open-Label Phase III AURELIA Trial Evaluating Bevacizumab-Containing Therapy for Platinum-Resistant Ovarian Cancer
001380 (2011) Chee K. Lee [Australie] ; Michael Friedlander [Australie] ; Chris Brown [Australie] ; Val J. Gebski [Australie] ; Alexander Georgoulopoulos [Autriche] ; Ignace Vergote [Belgique] ; Sandro Pignata [Italie] ; Nicoletta Donadello [Italie] ; Barbara Schmalfeldt [Allemagne] ; Remy Delva [France] ; Mansoor Raza Mirza [Danemark] ; Philippe Sauthier [Canada] ; Eric Pujade-Lauraine [France] ; Sarah J. Lord [Australie] ; R. John Simes [Australie]Early Decline in Cancer Antigen 125 as a Surrogate for Progression-Free Survival in Recurrent Ovarian Cancer

List of associated KwdEn.i

Nombre de
documents		Descripteur
2Cancerology
2Human
2Ovary cancer
2Prognosis
1Adult
1Aged
1Aged, 80 and over
1Antiangiogenic agent
1Antibodies, Monoclonal, Humanized (administration & dosage)
1Antibodies, Monoclonal, Humanized (adverse effects)
1Antineoplastic Combined Chemotherapy Protocols (adverse effects)
1Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
1Antineoplastic agent
1Bevacizumab
1CA 125 antigen
1Carbohydrate antigen
1Chemotherapy
1Doxorubicin (administration & dosage)
1Doxorubicin (adverse effects)
1Doxorubicin (analogs & derivatives)
1Doxorubicin (therapeutic use)
1Drug Administration Schedule
1Drug Resistance, Neoplasm
1Evolution
1Female
1Humans
1Immunomodulator
1Middle Aged
1Organoplatinum Compounds (pharmacology)
1Ovarian Neoplasms (drug therapy)
1Paclitaxel (administration & dosage)
1Paclitaxel (adverse effects)
1Paclitaxel (therapeutic use)
1Phase III trial
1Platinum
1Polyethylene Glycols (administration & dosage)
1Polyethylene Glycols (adverse effects)
1Polyethylene Glycols (therapeutic use)
1Progression free survival
1Relapse
1Self Report
1Topotecan (administration & dosage)
1Topotecan (adverse effects)
1Topotecan (therapeutic use)
1Treatment Outcome
1Treatment resistance
1Tumor associated antigen
1Tumoral marker
1Vascular endothelium growth factor

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Canada/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/Canada/Analysis/Author.i -k "Mansoor Raza Mirza" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Canada/Analysis/Author.i  \
                -Sk "Mansoor Raza Mirza" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Canada/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Canada
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Mansoor Raza Mirza
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024